Sara N Horst (Sara Horst)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Glycemic Control

Patients With Inflammatory Bowel Disease

Mesenchymal Stem Cells

Top Venues

JMIR research protocols

Crohn's & colitis 360

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas M Strobel, Nikita A Narayani, Maribeth R Nicholson, Diana C Riera, Tanner G Rakos, Nisa P Fulton, Jordan A Trotter-Busing, Sara N Horst, Robin L Dalal, Baldeep S Pabla, Elizabeth A Scoville, David A Schwartz, Dawn B Beaulieu
Young Adult Patient and Caregiver Perspectives on Transition Readiness in an Inflammatory Bowel Disease Clinic. Crohn's & colitis 360 6 (3) (2024)
Thomas M Strobel, Nikita A Narayani, Maribeth R Nicholson, Diana C Riera, Tanner G Rakos, Nisa P Fulton, Jordan A Trotter-Busing, Sara N Horst, Robin L Dalal, Baldeep S Pabla, Elizabeth A Scoville, David A Schwartz, Dawn B Beaulieu
Young Adult Patient and Caregiver Perspectives on Transition Readiness in an Inflammatory Bowel Disease Clinic. Crohn's & colitis 360 6 (3) (2024)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Katherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, Edward L Barnes, Abhik Bhattacharya, Jean Frederic Colombel, Raymond K Cross, Marcia S Driscoll, Anthony P Fernandez, Christina Ha, Hans Herfarth, Sara N Horst, Jason Hou, M Elaine Husni, Daniela Kroshinsky, Kristine A Kuhn, Careen Y Lowder, George Martin, Deep Parikh, Christopher J Sayed, Lisa Schocket, Bernadette C Siaton, Priyanka Vedak, Michael H Weisman, Florian Rieders
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (9) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Audrey Bennett, Sara N Horst
Editorial: maternal and paternal 5-aminosalicylic acid use-safe in conception and pregnancy. Alimentary pharmacology & therapeutics 56 (9) (2022)
C Alex Wiles, Nisha B Shah, Jake Bell, Baldeep S Pabla, Elizabeth A Scoville, Robin L Dalal, Dawn B Beaulieu, David A Schwartz, Sara N Horst
Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease. Crohn's & colitis 360 3 (4) (2021)
C Alex Wiles, Nisha B Shah, Jake Bell, Baldeep S Pabla, Elizabeth A Scoville, Robin L Dalal, Dawn B Beaulieu, David A Schwartz, Sara N Horst
Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease. Crohn's & colitis 360 3 (4) (2021)
Alexis Calloway, Robin Dalal, Dawn B Beaulieu, Caroline Duley, Kimberly Annis, Lawrence Gaines, Chris Slaughter, David A Schwartz, Sara N Horst
Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences 62 (12) (2017)